Latest From Biotech Now

The ‘What’s the Point’ Category for GMO Labeling Bills

label

Lawmakers have so much work to do, and few days left in which to do it. Formal sessions will end July 31. These bills and a slew of others should be organized under a new heading: ‘Don’t Bother.’ –The Boston Herald “A Back Burner Beckons,” July 21, 2014 Vermont has recently passed a state law that requires food manufacturers to label certain foods made with genetically modified organisms (GMOs). Vermont’s next door neighbor, Massachusetts, has similar Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Highlights the Importance of Care and Use of Animals at 2014 Livestock Biotech Summit

LBS-graphic-200x100 copy

The 2014 Summit will be held September 16-19, 2014, in Sioux Falls, South Dakota at the Sioux Falls Convention Center. Programming at this year’s Livestock Biotech Summit will address new methods for ensuring optimal care and use of agricultural animals for a range of applications. “Can you imagine a time when cures to life threatening diseases are developed faster and at less cost or when technologies to improve the environmental footprint of animal agriculture are Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

shutterstock_27160801

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology Hearing – Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients Witnesses Dr. Harold Varmus, Director, National Cancer Institute (NCI) at the National Institutes of Health (NIH) *(Really liked your DNA tie!) Dr. Marc Tessier-Lavigne, President and Carson Family Professor, Laboratory of Brain Development and Repair, The Rockefeller University Dr. Jay Keasling, Hubbard Howe Jr. Distinguished Professor of Biochemical Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Partnering Trends in Latin America

BIO-One-On-One

If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making and partnering growth in Brazil and the rest of Latin America provide good reason to put the “B” in front. Traditional partnerships (i.e. excluding M&A and early venture funding) where a Latin American company served as the ‘seller’ or ‘out-licensor’ doubled per year from 2009/2010 to 2012. While there was a pullback in 2013, overall growth from 2009/2010 to 2013 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

partnering1

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their hats into the ring. These three biotechs are targeting $175M in IPO cash, hoping to secure funding for oncology, pain, and rare diseases. In fact, there have been 96 IPOs since the passage of the JOBS Act in April of 2012. One important provision of the Act is the ability for emerging growth companies to conduct “testing the waters” meetings with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,